Vilobelimab
Product Specifications
CAS Number
2250440-41-4
Target
SARS-CoV|||Complement System
Related Pathways
Immunology/Inflammation|||Microbiology/Virology
Purity
0.99
Bioactivity
Vilobelimab (CaCP-29) is a human-mouse chimeric IgG antibody targeting human complement component 5a, a C5a inhibitor that inhibits neutrophil activation, and can be used for the study of systemic inflammation caused by SARS-CoV-2 infection.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS4516791-01 20 Tests
Anti-Human TCR gamma/delta Monoclonal Antibody (AF647 Conjugated)
Ask
View Details MBS4516791-02 50 Tests
Anti-Human TCR gamma/delta Monoclonal Antibody (AF647 Conjugated)
Ask
View Details MBS4516791-03 100 Tests
Anti-Human TCR gamma/delta Monoclonal Antibody (AF647 Conjugated)
Ask
View Details MBS4516791-04 5x 100 Tests
Anti-Human TCR gamma/delta Monoclonal Antibody (AF647 Conjugated)
Ask
View Details